Hunan Hansen Pharmaceutical Co Ltd (002412) — Net Asset Quality Index
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Net Asset Quality Index of 88.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.56 Billion minus total liabilities of CN¥301.66 Million yields net assets of CN¥2.26 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Hunan Hansen Pharmaceutical Co Ltd (002412) asset resilience to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Hunan Hansen Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2006–2024)
This chart shows how Hunan Hansen Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2006 to 2024. As of September 2025, the index stands at 88.2%, representing net assets of CN¥2.26 Billion against total assets of CN¥2.56 Billion CNY. See Hunan Hansen Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Hunan Hansen Pharmaceutical Co Ltd (2006–2024)
The table below presents the year-by-year Net Asset Quality Index for Hunan Hansen Pharmaceutical Co Ltd from 2006 to 2024, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market value of Hunan Hansen Pharmaceutical Co Ltd.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 86.5% | CN¥2.20 Billion | CN¥2.55 Billion | CN¥343.85 Million | ▲ +2.5 pp |
| 2023 | 84.0% | CN¥1.96 Billion | CN¥2.34 Billion | CN¥373.46 Million | ▲ +1.3 pp |
| 2022 | 82.7% | CN¥1.89 Billion | CN¥2.29 Billion | CN¥396.81 Million | ▲ +0.2 pp |
| 2021 | 82.5% | CN¥1.74 Billion | CN¥2.11 Billion | CN¥368.99 Million | ▼ -1.9 pp |
| 2020 | 84.4% | CN¥1.59 Billion | CN¥1.89 Billion | CN¥293.92 Million | ▲ +3.2 pp |
| 2019 | 81.3% | CN¥1.53 Billion | CN¥1.88 Billion | CN¥352.93 Million | ▲ +5.4 pp |
| 2018 | 75.8% | CN¥1.36 Billion | CN¥1.80 Billion | CN¥435.02 Million | ▲ +4.1 pp |
| 2017 | 71.7% | CN¥1.22 Billion | CN¥1.70 Billion | CN¥481.18 Million | ▼ -3.5 pp |
| 2016 | 75.2% | CN¥1.26 Billion | CN¥1.67 Billion | CN¥415.88 Million | ▼ -15.6 pp |
| 2015 | 90.8% | CN¥1.25 Billion | CN¥1.38 Billion | CN¥126.83 Million | ▲ +6.5 pp |
| 2014 | 84.3% | CN¥1.15 Billion | CN¥1.37 Billion | CN¥214.59 Million | ▲ +0.5 pp |
| 2013 | 83.8% | CN¥1.11 Billion | CN¥1.32 Billion | CN¥214.46 Million | ▼ -8.9 pp |
| 2012 | 92.6% | CN¥965.11 Million | CN¥1.04 Billion | CN¥76.76 Million | ▼ -1.5 pp |
| 2011 | 94.1% | CN¥883.65 Million | CN¥938.60 Million | CN¥54.95 Million | ▼ -0.7 pp |
| 2010 | 94.8% | CN¥898.82 Million | CN¥948.05 Million | CN¥49.23 Million | ▲ +22.2 pp |
| 2009 | 72.6% | CN¥179.51 Million | CN¥247.20 Million | CN¥67.69 Million | ▲ +12.0 pp |
| 2008 | 60.6% | CN¥130.26 Million | CN¥214.93 Million | CN¥84.67 Million | ▲ +10.2 pp |
| 2007 | 50.4% | CN¥87.77 Million | CN¥174.25 Million | CN¥86.49 Million | ▲ +18.6 pp |
| 2006 | 31.8% | CN¥67.28 Million | CN¥211.73 Million | CN¥144.46 Million | — |